This content is only available within our institutional offering.

25 Aug 2022
Faron Pharmaceuticals (Buy) - 1H22: clinical progression for an exciting oncology asset

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Faron Pharmaceuticals (Buy) - 1H22: clinical progression for an exciting oncology asset
Faron Pharmaceuticals Oy (FARN:LON) | 178 0 0.0% | Mkt Cap: 201.6m
- Published:
25 Aug 2022 -
Author:
Miles Dixon -
Pages:
5 -